Physician profile
Efren Caballes
NPI 1760770879
$552.36
in general payments reported to CMS, 2019-2025
9 companies · $29.27 in 2025
The $29.27 reported for 2025 was less than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2021: $26.64 · 2022: $18.35 · 2024: $50.84 · 2025: $29.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $282.67 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $113.89 | 2019 | |
| Bioventus LLC | $34.52 | 2024-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Ossur Americas, INC. | $30.84 | 2024 | Miami J |
| Samsung Hme America, INC. | $30.00 | 2019 | |
| Fidia Pharma USA INC. | $18.35 | 2022 | |
| Biotissue Holdings INC. | $14.75 | 2025 | |
| Abbott Laboratories | $14.13 | 2021 | |
| Depuy Synthes Sales INC. | $13.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Efren Caballes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.